KLSE (MYR): KPJ (5878)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.90
Today's Change
-0.04 (2.06%)
Day's Change
1.89 - 1.96
Trading Volume
9,079,900
Market Cap
8,601 Million
NOSH
4,527 Million
Latest Quarter
31-Dec-2023 [#4]
Announcement Date
16-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
30-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
-18.74% | 1.81%
Revenue | NP to SH
3,465,341.000 | 262,543.000
RPS | P/RPS
76.55 Cent | 2.48
EPS | P/E | EY
5.80 Cent | 32.76 | 3.05%
DPS | DY | Payout %
3.23 Cent | 1.70% | 55.65%
NAPS | P/NAPS
0.51 | 3.72
QoQ | YoY
0.5% | 49.46%
NP Margin | ROE
7.78% | 11.36%
F.Y. | Ann. Date
31-Dec-2023 | 16-Feb-2024
Latest Audited Result
31-Dec-2022
Announcement Date
27-Apr-2023
Next Audited Result
31-Dec-2023
Est. Ann. Date
27-Apr-2024
Est. Ann. Due Date
28-Jun-2024
Revenue | NP to SH
3,418,701.000 | 263,408.000
RPS | P/RPS
75.52 Cent | 2.52
EPS | P/E | EY
5.82 Cent | 32.65 | 3.06%
DPS | DY | Payout %
3.23 Cent | 1.70% | 55.46%
NAPS | P/NAPS
0.51 | 3.72
YoY
53.15%
NP Margin | ROE
7.91% | 11.40%
F.Y. | Ann. Date
31-Dec-2023 | 16-Feb-2024
Revenue | NP to SH
3,418,701.000 | 263,408.000
RPS | P/RPS
75.52 Cent | 2.52
EPS | P/E | EY
5.82 Cent | 32.65 | 3.06%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
4.44% | 53.15%
NP Margin | ROE
7.91% | 11.40%
F.Y. | Ann. Date
31-Dec-2023 | 16-Feb-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Dividend | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Dividend Growth | 3 / 4 | 75.00% | 3 / 8 | 37.50% |
Continuous Quarters Of Adjusted Dps Growth | 3 / 4 | 75.00% | 3 / 8 | 37.50% |
Average ROE | 2.91% | 2.49% | ||
Average Net Profit Margin | 7.69% | 7.04% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 3 / 5 | 60.00% | 3 / 10 | 30.00% |
Total Positive Profit Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Profit Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted EPS Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Dividend Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Dividend Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted Dps Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Average ROE | 7.82% | 11.57% | ||
Average Net Profit Margin | 5.57% | 5.51% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 3,465,341 | 3,418,701 | 3,418,701 | 2,988,333 | 2,993,603 |
NP to SH | 262,543 | 263,408 | 263,408 | 158,251 | 161,648 |
Dividend | 146,093 | 146,093 | 146,093 | 85,045 | 78,661 |
Adjusted EPS | 5.80 | 5.82 | 5.82 | 3.50 | 3.57 |
Adjusted DPS | 3.23 | 3.23 | 3.23 | 1.88 | 1.74 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | -1.51% | 16.71% | 17.05% | 5.21% | 13.68% |
NP to Owner | -18.74% | 1.81% | 53.15% | 11.81% | 33.98% |
Dividend | 62.50% | 30.59% | 68.26% | 55.22% | 94.72% |
Adjusted EPS | -18.74% | 1.81% | 53.15% | 11.81% | 33.98% |
Adjusted DPS | 62.50% | 30.59% | 68.26% | 55.22% | 94.72% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 1.36% | 15.76% | 15.96% | 0.00% | 14.20% | 14.40% | 17.05% | 14.20% | 14.40% |
NP to Owner | -0.33% | 62.42% | 65.90% | 0.00% | 62.95% | 66.45% | 53.15% | 62.95% | 66.45% |
Dividend | 0.00% | 85.73% | 71.78% | 0.00% | 85.73% | 71.78% | 68.26% | 85.73% | 71.78% |
Adjusted EPS | -0.33% | 62.42% | 65.90% | 0.00% | 62.95% | 66.45% | 53.15% | 62.95% | 66.45% |
Adjusted DPS | 0.00% | 85.73% | 71.78% | 0.00% | 85.73% | 71.78% | 68.26% | 85.73% | 71.78% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
3 Black crows appeared, take some profit first then wait for it to fall to support.
1 month ago
Now with the consolidation exercises going on within the private market, this is certainly an attractive stock to own given KPJ's geographical distribution within Malaysia and at this stock price it looks like a prime acquisition target, since now it's mostly about IHH vs HLB-TPG. Anyone who acquires KPJ would certainly gain the leading standing in terms of market share within the country. If you look at it from that perspective, KPJ sits pretty while waiting for suitors to slip it a glass slipper.
3 weeks ago
I suggest KPJ should sue their own patients for damaging reviews on google for RM1 million each patient.
maybe that will help coz damaging reviews been ongoing for many many years non-stop.
//////Came for influenza vaccination. Staff nurse in charge did not show the ampoule & withdraw in front of patient prior to vaccination. This should be the proper procedure.
Cashier was slow. Had to wait for 40 mins just to settle payment for the vaccination. It should be faster for cash paying patient, for vaccination. They put us on queue together with the rest of patients accessing ED! Exposing us to infection. There’s not enough chairs for the waiting area. Perhaps can improve in the future - for wellness/ preventive activities at different area from ED to prevent cross infection.////
https://www.google.com/maps/place/KPJ+Kajang+Specialist+Hospital/@2.9999093,101.7857178,17z/data=!3m1!4b1!4m6!3m5!1s0x31cdcb6a7b9159bb:0xbdba972eb9b60d5e!8m2!3d2.9999093!4d101.7857178!16s%2Fg%2F1tf6jqjg?entry=ttu
3 weeks ago
Both KPJ Damansara and KPJ Kajang had been getting very extremely bad patient reviews for years and years.
I only found out when I looked at Google maps recently.
Since only small % of people give comments, looks like a huge problem in quality control.
3 weeks ago
Kpj 1.72
3-5 trading days upward,tht it.prepare for correction.
10/3/24 4.50pm
2 weeks ago
JERUNG sudah habis jual - EPF /KWAP.....bila oraang mau stop jual ? mau beli ooh
1 week ago
ElijahYH
It's moving oppositely with OSK's TP 😂
2 months ago